Cigna Group (NYSE:CI) Price Target Lowered to $333.00 at Royal Bank Of Canada

Cigna Group (NYSE:CI) had its target price cut by Royal Bank Of Canada from $344.00 to $333.00 in a research report report published on Friday, MarketBeat reports. They currently have an outperform rating on the health services provider’s stock.

Several other equities analysts have also recently commented on the stock. Wells Fargo & Company lowered their target price on shares of Cigna Group from $354.00 to $300.00 and set an “equal weight” rating on the stock in a research note on Wednesday, November 5th. Wall Street Zen lowered shares of Cigna Group from a “buy” rating to a “hold” rating in a research note on Saturday, January 24th. Leerink Partners decreased their price target on Cigna Group from $300.00 to $270.00 in a research note on Friday, October 31st. The Goldman Sachs Group lowered their price target on Cigna Group from $370.00 to $330.00 and set a “buy” rating on the stock in a research report on Tuesday, November 4th. Finally, TD Cowen set a $333.00 price objective on Cigna Group in a report on Monday, December 15th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $323.16.

Cigna Group Stock Performance

CI opened at $292.29 on Friday. The company has a current ratio of 0.74, a quick ratio of 0.76 and a debt-to-equity ratio of 0.74. The business’s 50 day moving average is $274.77 and its 200-day moving average is $283.95. The stock has a market cap of $78.08 billion, a PE ratio of 13.18, a price-to-earnings-growth ratio of 1.01 and a beta of 0.27. Cigna Group has a twelve month low of $239.51 and a twelve month high of $350.00.

Cigna Group (NYSE:CI) last posted its earnings results on Thursday, February 5th. The health services provider reported $8.08 EPS for the quarter, beating the consensus estimate of $7.88 by $0.20. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The firm had revenue of $72.50 billion for the quarter, compared to analysts’ expectations of $69.53 billion. During the same period last year, the firm earned $6.64 EPS. The firm’s revenue was up 10.4% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.250- EPS. On average, analysts predict that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, March 19th. Shareholders of record on Thursday, March 5th will be paid a dividend of $1.56 per share. This is an increase from Cigna Group’s previous quarterly dividend of $1.51. The ex-dividend date of this dividend is Thursday, March 5th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.1%. Cigna Group’s dividend payout ratio (DPR) is 26.64%.

Institutional Trading of Cigna Group

Hedge funds and other institutional investors have recently modified their holdings of the company. Harbor Capital Advisors Inc. increased its position in Cigna Group by 119.5% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock worth $26,000 after purchasing an additional 49 shares during the last quarter. Beacon Financial Strategies CORP acquired a new position in Cigna Group in the fourth quarter worth approximately $28,000. Solstein Capital LLC bought a new position in Cigna Group during the second quarter valued at approximately $29,000. Chilton Capital Management LLC bought a new stake in Cigna Group in the second quarter worth approximately $30,000. Finally, Princeton Global Asset Management LLC increased its stake in shares of Cigna Group by 115.6% during the 2nd quarter. Princeton Global Asset Management LLC now owns 97 shares of the health services provider’s stock worth $32,000 after purchasing an additional 52 shares during the last quarter. 86.99% of the stock is currently owned by hedge funds and other institutional investors.

Trending Headlines about Cigna Group

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Q4 earnings and revenue beat — Cigna reported adjusted EPS of $8.08 and revenue of $72.5B, both above consensus, driven by Evernorth growth and higher specialty volumes; investors are rewarding the beat and evidence of durable revenue momentum. Cigna Q4 Highlights
• Positive Sentiment: FTC settlement over insulin pricing reduces regulatory overhang and includes commitments to change PBM pricing practices — this removes a major legal uncertainty and may support multiple expansion. FTC Settlement Coverage
• Positive Sentiment: Dividend increase — the board raised the quarterly dividend to $1.56 (3.3% increase), a modest buyback/dividend-friendly signal that supports income investors. Dividend Announcement
• Neutral Sentiment: Analyst price target moves are mixed — Leerink raised its PT to $297 but kept a “market perform” rating, while RBC trimmed its PT to $333 but maintained an “outperform” view; these moves show cautious optimism but limited near-term upside consensus. Leerink PT Change RBC PT Change
• Neutral Sentiment: Evernorth and specialty volumes are growth drivers cited on the call — supportive for revenue mix and long-term profit potential, though investors will watch margin dynamics. Evernorth Growth Coverage
• Negative Sentiment: 2026 guidance slightly below some Street expectations — Cigna set FY 2026 EPS guidance at at least $30.25, a touch under consensus and accompanied by commentary about ongoing medical-cost and margin pressure; this tempered the upside from the quarter for some investors. Guidance Miss Coverage

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.